| Released | Contributor | Author | Title | Pages | Price |
| 5-Dec-2009 | Standard & Poor's Quantitative Report |
N/A
| Anesiva Inc | 5 |
$25 |
| 4-Dec-2009 | Pechala's Reports | Lubomir Pechala | ANESIVA INC (ANSV=US) 2-weeks forecast | 1 |
$10 |
| 4-Dec-2009 | New Constructs, LLC |
N/A
| ANSV: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 3-Dec-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for DRUGS | 18 |
$49 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Value Graph: ANESIVA -- ANSV | 1 |
$4 |
| 3-Dec-2009 | RiskMetrics Group |
N/A
| ISS Report on Anesiva, Inc. | 30 |
$135 |
| 3-Dec-2009 | Ford Investor Services, Inc. |
N/A
| Industry Value Graph: ALXN , ANSV , DCGN , HGSI , IDRA -- DRUGS | 3 |
$4 |
| 30-Nov-2009 | Wall Street Transcript ,The | The Wall St Transcript | MANAGEMENT TURNOVER REPORT - Anesiva Inc. (ANSV) | 6 |
$50 |
| 30-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Detailed Valuation Report for ANSV | 13 |
$25 |
| 29-Nov-2009 | Wright Reports |
N/A
| Wright Investors Service Comprehensive Report for Anesiva, Inc. | 40 |
$65 |
0.22% Nasdaq 
0.0046 (3.42%) 
Research Reports
